Kotra Industries Bhd
KLSE:KOTRA
Kotra Industries Bhd
Revenue
Kotra Industries Bhd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Revenue
myr235.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Revenue
myr176m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Revenue
myr961.8m
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Revenue
myr211.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Revenue
myr368.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Revenue
myr787.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
16%
|
|
Kotra Industries Bhd
Glance View
Kotra Industries Bhd.is an investment holding company, which engages in the manufacturing and trading of pharmaceutical and healthcare products. The company is headquartered in Malacca, Melaka and currently employs 660 full-time employees. The company went IPO on 2000-10-30. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd, is engaged in pharmaceutical and healthcare products manufacturing and trading business. Its segments include Malaysia, Asia and Africa. Its products include Appeton Multivitamin Pastilles, which is a healthy chewable pastille (non-sugar coated) for children; Axcel Glimepiride Medication, which is used to treat diabetes mellitus type 2; Axcel Bromhexine (Children) Syrup, which is a mucolytic medicine used in the treatment of respiratory chest congestion; Arite Beclometasone 50mcg (Metered Dose Inhaler Product), which is used in long-term management of asthma; Vaxcel Granisetron Injection, which is an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy, and Axcel Atenolol, which is used to treat high blood pressure and heart-associated chest pain.
See Also
What is Kotra Industries Bhd's Revenue?
Revenue
235.7m
MYR
Based on the financial report for Dec 31, 2024, Kotra Industries Bhd's Revenue amounts to 235.7m MYR.
What is Kotra Industries Bhd's Revenue growth rate?
Revenue CAGR 10Y
4%
Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Kotra Industries Bhd have been 7% over the past three years , 7% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet